James Frincke, based in California, United States, is currently a Founder || President and CEO | Research | Development | Executive Management at Immunikas, LLC/Red Spot Biosciences, LLC, bringing experience from previous roles at Harbor Therapeutics (acquired by Crede Capitol Group), Prolinx (acquired by Canbera), Systemix, Inc (acquired by Novartis) and Eli Lilly and Company. James Frincke holds a 1987 - 1988 Certificate in Executive Program for Scientists and Engineers @ University of California, San Diego. With a robust skill set that includes Infectious Diseases, JavaScript, Monoclonal Antibodies, Patents, Professional Management and more, James Frincke contributes valuable insights to the industry. James Frincke has 1 email on RocketReach.